Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Puig

Showing results (391-400 of 423) with videos related to

Pageof 43
Sort By:
Archives of Orthopaedic and Trauma Surgery|May 7, 2015
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trialX Aguilera, M J Martínez-Zapata, P Hinarejos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 15, 2018
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective studyG Deza, J Notario, A Lopez-Ferrer, et al.
Actas Dermo-Sifiliograficas|June 30, 2009
[Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]L Puig, J M Carrascosa, E Daudén, et al.
Actas Dermo-Sifiliograficas|February 24, 2024
Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish PatientsJ Montero-Menárguez, V Amat Samaranch, L Puig Sanz, et al.
Sangre|January 1, 1981
[Allogenic bone-marrow transplantation in severe marrow aplasia. Analysis of 12 consecutive cases (author's transl)]C Rozman, A Grañena, P Marín, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 1, 2019
Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasisP de la Cueva Dobao, J Notario, C Ferrándiz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2021
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyondJ Beecker, K A Papp, J Dutz, et al.
The Journal of Dermatological Treatment|February 20, 2014
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paperG Girolomoni, C E M Griffiths, J Krueger, et al.
The British Journal of Dermatology|March 17, 2017
Reaching complete or near-complete resolution of psoriasis: benefit and risk considerationsA Blauvelt, C E M Griffiths, M Lebwohl, et al.
The British Journal of Dermatology|September 7, 2018
Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trialsB E Strober, A B Gottlieb, P C M van de Kerkhof, et al.
Pageof 43

Showing results (391-400 of 423) with videos related to

Sort By:
Pageof 43
Archives of Orthopaedic and Trauma Surgery|May 7, 2015
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trialX Aguilera, M J Martínez-Zapata, P Hinarejos, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 15, 2018
Initial results of ixekizumab efficacy and safety in real-world plaque psoriasis patients: a multicentre retrospective studyG Deza, J Notario, A Lopez-Ferrer, et al.
Actas Dermo-Sifiliograficas|June 30, 2009
[Spanish evidence-based guidelines on the treatment of moderate-to-severe psoriasis with biologic agents]L Puig, J M Carrascosa, E Daudén, et al.
Actas Dermo-Sifiliograficas|February 24, 2024
Pityriasis Rubra Pilaris: A Multicentric Case Series of 65 Spanish PatientsJ Montero-Menárguez, V Amat Samaranch, L Puig Sanz, et al.
Sangre|January 1, 1981
[Allogenic bone-marrow transplantation in severe marrow aplasia. Analysis of 12 consecutive cases (author's transl)]C Rozman, A Grañena, P Marín, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 1, 2019
Expert consensus on the persistence of biological treatments in moderate-to-severe psoriasisP de la Cueva Dobao, J Notario, C Ferrándiz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 3, 2021
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyondJ Beecker, K A Papp, J Dutz, et al.
The Journal of Dermatological Treatment|February 20, 2014
Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paperG Girolomoni, C E M Griffiths, J Krueger, et al.
The British Journal of Dermatology|March 17, 2017
Reaching complete or near-complete resolution of psoriasis: benefit and risk considerationsA Blauvelt, C E M Griffiths, M Lebwohl, et al.
The British Journal of Dermatology|September 7, 2018
Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trialsB E Strober, A B Gottlieb, P C M van de Kerkhof, et al.
Pageof 43